NCT05314439View on ClinicalTrials.gov

A Study to Assess the Safety, Tolerability, and Efficacy of Monthly Subcutaneous Administration of ION904 in Participants With Uncontrolled Hypertension

PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

April 29, 2022

Primary Completion Date

January 31, 2023

Study Completion Date

February 15, 2023

Conditions
Hypertension
Interventions
DRUG

ION904

ION904 will be administered by SC injection.

DRUG

Placebo

Placebo will be administered by SC injection.

Trial Locations (8)

11235

NY Scientific, Brooklyn

32127

Progressive Medical Research, Port Orange

33024

ALL Medical Research, LLC, Cooper City

66212

Altasciences, Overland Park

77040

Juno Research, LLC, Houston

90057

National Research Institute, Los Angeles

90630

Altasciences - Los Angeles, Cypress

95821

Clinical Trials Research, Sacramento

Sponsors
All Listed Sponsors
lead

Ionis Pharmaceuticals, Inc.

INDUSTRY